findmyKOL
Clinical trialNCT00695292CompletedPhase 2Interventional

Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer

SponsorSCRI Development Innovations, LLCEnrollment37Small Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Florida Cancer Specialists

    Fort Myers, Florida, United States

  • Florida Hospital Cancer Insitute

    Orlando, Florida, United States

  • Northeast Georgia Medical Center

    Gainesville, Georgia, United States

  • Baton Rouge General Medical Center

    Baton Rouge, Louisiana, United States

  • Center for Cancer and Blood Disorders

    Bethesda, Maryland, United States

  • St. Louis Cancer Care

    Chesterfield, Missouri, United States

  • Oncology Hematology Care

    Cincinnati, Ohio, United States

  • Spartanburg Regional Medical Center

    Spartanburg, South Carolina, United States

  • Chattanooga Oncology Hematology Associates

    Chattanooga, Tennessee, United States

  • Tennessee Oncology

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2008
Primary completion
30 Jun 2011
Completion
30 Sept 2012
Last update posted
22 Nov 2021
Registered enrollment
37
Registry id
NCT00695292

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.